NOT-CA-14-008: Notice of Correction to PAR-13-386 "Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)"

Notice of Correction to PAR-13-386 "Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)"

Notice Number: NOT-CA-14-008

Key Dates
Release Date: November 20, 2013

Related Announcements
NOT-CA-16-038
October 19, 2015 - Notice of Correction PAR-13-386. See Notice NOT-CA-15-043.
PAR-13-386

Issued by
National Cancer Institute (NCI)

Purpose

On November 7, 2013, the NCI published PAR-13-386 "Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)."

The purpose of this Notice is to amend the Funding Opportunity Announcement (FOA) in the following sections:

Section IV.2. Content and Form of Application Submission

Research and Related Other Project Information (Clinical Protocol and Data Management)

Other Attachments:
The following paragraph is added to Part II. For the Inclusion of Women and Minorities:

Accrual. Using the official NIH gender and racial/ethnic categories and subcategories, provide summary accrual information from the most recent 12-month period for all clinical research studies conducted at the center in each of the following areas: (a) interventional therapeutic clinical trials, (b) interventional non-therapeutic clinical trials, and (c) non- interventional epidemiologic, observational, and outcome studies. Relate this information to the demographic information provided above.

Section IV.2. Content and Form of Application Submission

Research and Related Other Project Information (Research Programs)

Other Attachments:
The following paragraph is added to this section:

For programs with clinical trials, a table providing a summary of accrual to interventional clinical trials over the four years preceding the renewal application, by source of support (National, Industry, Externally Peer-reviewed, and Institutional).

Section IV.2. Content and Form of Application Submission

PHS 398 Research Plan (Research Programs)

Research Strategy:
The following paragraph should be deleted:

Accrual of patients to interventional clinical trials over the project period preceding the current application, including a brief overview of accrual by types of trials (national, institutional, externally peer-reviewed and industry)

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Office of Cancer Centers
National Cancer Institute (NCI)
Telephone: 240-276-5600
Email: [email protected]